CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 240 target
Drug / intervention
Oxygen +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00327873
NCT00327873N/ACompleted
CompareCT.gov

A Multi-center Randomized Double-blind Controlled Trial of Oxygen Versus Medical Air for the Relief of Breathlessness in Patients With Intractable Dyspnea and PaO2>55mmHg

National Health and Medical Research Council, Australia·interventional·Posted May 19, 2006·Updated Dec 14, 2009

In Brief

A clinical study evaluating Oxygen and Medical Air for Dyspnea. Completed, enrolled 240 participants across 7 sites in 3 countries.

Detailed Summary

The main goal of this study is to establish the effectiveness of palliative oxygen in the context within which it is usually provided--relief of the sensation of breathlessness and improvement in quality of life for people with maximally-treated life-limiting illness.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDyspnea
CountriesAustralia, United Kingdom, United States
CollaboratorsDoris Duke Charitable Foundation, Cancer Council Tasmania, Duke Institute on Care at the End of Life, USA, Flinders Medical Research Institute Small Research Grants Scheme, Australia

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 19, 2006
Enrollment StartMay 1, 2005
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 20.1 years ago

Interventions

Oxygenother

2L/min for 15 hours or greater per day via concentrator and nasal cannulae for 7 days

Medical Airother

2L/min for 15 hours or greater per day via concentrator and nasal cannulae for 7 days